Search - tctmd.com

Displaying 101 - 120 of 289

Sort: Relevancy | Date

Presentation NY Valves 2025

TAVR Reintervention Strategies: Unveiling Trends and Outcomes of Redo TAVR and TAVR Explant

Presenter: Shinichi Fukuhara

June 25, 2025

Presentation NY Valves 2025

Patient Selection in Tricuspid TEER: Imaging and Clinical Predictors of Success

Presenter: Fabien Praz

June 25, 2025

Presentation NY Valves 2025

Electronic Provider Notification Mitigates Sex Disparities in the Treatment of Severe Aortic Stenosis: Insights From the DETECT AS Trial

Presenter: Sammy Elmariah

June 25, 2025

Presentation NY Valves 2025

Clinical Trials Update: Real-World Tricuspid TEER Registries

Presenter: Jörg Hausleiter

June 25, 2025

Presentation NY Valves 2025

Impact of Spontaneous Echo Contrast on Clinical Outcomes After Left Atrial Appendage Occlusion

Presenter: Sachiyo Ono

June 25, 2025

Presentation NY Valves 2025

Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial

Presenter: Allan Schwartz

June 25, 2025

Presentation NY Valves 2025

Clinical Update from RCTs in Tricuspid TEER (Tri-FR and TRILUMINATE)

Presenter: Erwan Donal

June 25, 2025

Presentation NY Valves 2025

M-TEER for Atrial and Ventricular SMR: Insights from the REPAIR Study

Presenter: Philipp von Stein

June 25, 2025

Presentation NY Valves 2025

Clipping Strategies and Outcomes in Atrial SMR Patients Treated with the MitraClip System

Presenter: Mark J. Ricciardi

June 25, 2025

Presentation NY Valves 2025

Effect of TTVR on Preference-Weighted Health Status: A Patient-Centered Sub-Study of the TRISCEND II Pivotal Trial

Presenter: Suzanne V. Arnold

June 25, 2025

Presentation NY Valves 2025

Early Outcomes of Real-World TTVR (Evoque)

Presenter: Fabien Praz

June 25, 2025

Presentation NY Valves 2025

Clinical and Economic Outcomes by Stage of Cardiac Damage and Clinical Presentation at Aortic Valve Replacemen

Presenter: Philippe Genereux

June 25, 2025

Presentation NY Valves 2025

Structuralist Viewpoint

Presenter: Ralph Stephan von Bardeleben

June 25, 2025

Presentation NY Valves 2025

Surgical Viewpoint

Presenter: Michael A. Borger

June 25, 2025

Presentation NY Valves 2025

Case Resolution

Presenter: Nino Mihatov

June 25, 2025

Presentation NY Valves 2025

The Imager Perspective: Can Imaging Insights Determine Optimal Treatment Strategy?

Presenter: Konstantinos P. Koulogiannis

June 25, 2025

Presentation NY Valves 2025

The Structuralists Perspective: Why Not Try Mitral TEER First? (Surgery Can Always Be a Later Option)

Presenter: Sam Dawkins

June 25, 2025

Presentation NY Valves 2025

The Mitral Surgeon’s Perspective: High Risk Surgery is Better than Sub-Optimal Mitral TEER!

Presenter: Arnar Geirsson

June 25, 2025

Presentation NY Valves 2025

Case Presentation: Primary MR in a High-Surgical Risk Patient with “Yellow-Zone” Anatomy

Presenter: Nino Mihatov

June 25, 2025

News Conference News NY Valves 2024

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

Todd Neale

June 14, 2024

Advertisement

TAVR Reintervention Strategies: Unveiling Trends and Outcomes of Redo TAVR and TAVR Explant

Patient Selection in Tricuspid TEER: Imaging and Clinical Predictors of Success

Electronic Provider Notification Mitigates Sex Disparities in the Treatment of Severe Aortic Stenosis: Insights From the DETECT AS Trial

Clinical Trials Update: Real-World Tricuspid TEER Registries

Impact of Spontaneous Echo Contrast on Clinical Outcomes After Left Atrial Appendage Occlusion

Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial

Clinical Update from RCTs in Tricuspid TEER (Tri-FR and TRILUMINATE)

M-TEER for Atrial and Ventricular SMR: Insights from the REPAIR Study

Clipping Strategies and Outcomes in Atrial SMR Patients Treated with the MitraClip System

Effect of TTVR on Preference-Weighted Health Status: A Patient-Centered Sub-Study of the TRISCEND II Pivotal Trial

Early Outcomes of Real-World TTVR (Evoque)

Clinical and Economic Outcomes by Stage of Cardiac Damage and Clinical Presentation at Aortic Valve Replacemen

Structuralist Viewpoint

Surgical Viewpoint

Case Resolution

The Imager Perspective: Can Imaging Insights Determine Optimal Treatment Strategy?

The Structuralists Perspective: Why Not Try Mitral TEER First? (Surgery Can Always Be a Later Option)

The Mitral Surgeon’s Perspective: High Risk Surgery is Better than Sub-Optimal Mitral TEER!

Case Presentation: Primary MR in a High-Surgical Risk Patient with “Yellow-Zone” Anatomy

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content